Positively Aware Baraclude HBV

Baraclude

entecavir (ETV)

 
Nucleoside "Nuke"

Standard Dose

Adult (age 16 and older): Treatment-naïve with no resistance, one 0.5 mg tablet once daily on an empty stomach (no food 2 hours before or 2 hours after taking pill); if lamivudine or telbivudine (brand name Tyzeka, discontinued since December 2016) resistant, 1 mg once daily on an empty stomach. Adult with decompensated liver disease: 1 mg once per day. Dose adjustments needed for individuals with kidney disease. See positivelyaware.com/baraclude and consult a medical provider for more detail.

Pediatric (ages 2–15): Weight-based dosing required. It’s complicated, and should be managed in consultation with an experienced medical provider.

Manufacturer

Bristol-Myers Squibb

AWP

brand, 0.5 mg and 1 mg tablets: $1,647 / month
generic, 0.5 mg and 1 mg tablets: $1,300 / month

Potential Side Effects and Toxicity

Potential Drug Interactions

More Information